Additional antibiotic inhibitors of peptidoglycan synthesis.
about
Formation of the glycan chains in the synthesis of bacterial peptidoglycanAlanine scan of [L-Dap(2)]ramoplanin A2 aglycon: assessment of the importance of each residue.Biosynthesis and biological activities of lantibiotics with unique post-translational modifications.Cell envelope stress response in cell wall-deficient L-forms of Bacillus subtilisChemistry and biology of the ramoplanin family of peptide antibiotics.Expanding role of lipid II as a target for lantibiotics.Therapeutic potential of type A (I) lantibiotics, a group of cationic peptide antibiotics.Discovery and development of lantibiotics; antimicrobial agents that have significant potential for medical application.In vitro synthesis of peptidoglycan by beta-lactam-sensitive and -resistant strains of Neisseria gonorrhoeae: effects of beta-lactam and other antibiotics.Inhibition of peptidoglycan biosynthesis in gram-positive bacteria by LY146032Gardimycin, a new antibiotic inhibiting peptidoglycan synthesis.Lipid II-mediated pore formation by the peptide antibiotic nisin: a black lipid membrane studyPapulacandin B: an inhibitor of glucan synthesis in yeast spheroplasts.Molecular mechanism of target recognition by subtilin, a class I lanthionine antibiotic.Anchoring of surface proteins to the cell wall of Staphylococcus aureus. III. Lipid II is an in vivo peptidoglycan substrate for sortase-catalyzed surface protein anchoring.Inhibition of cell wall synthesis by the antibiotics diumycin and janiemycin.Biosynthesis and Biological Activities of Lantibiotics with Unique Post-Translational Modifications
P2860
Q28185380-6EDBAB5A-FA0C-44D5-9465-B67027B056B4Q33288904-6CF88F84-1198-468F-AD56-72DADC261785Q34299091-07896EBC-3456-404C-A297-90D80BF3D1B2Q34410541-A541F597-577D-482D-B2BA-DDE03607D528Q35030299-723F98D6-67DC-4C4F-B5B7-84BE8B8C2480Q36967247-2DB0296C-3CCC-4195-9F1B-86A65130D682Q37291766-DD10D7DF-9183-4FA7-9FCF-1897EFA7EF30Q38014580-377C77AD-92A5-42E1-8E82-74841960803EQ39681269-B644BA0F-610E-4A49-B70C-C8C1CEF84D0FQ39828406-38047AAF-2FB8-49EC-9BC2-22430DC54DBDQ40616918-88BA2148-92E2-4FFF-88AA-4EBB6B19EFB8Q40816308-6B4208B3-5E25-4854-B7AC-974B0AA0CFB2Q41078788-17BD59E8-9B5E-4744-8801-78F0E8C3FD3FQ41915246-829280D6-C9AA-493E-927B-0058A0524904Q45714101-67C458D0-6165-4651-A05B-4C85EC590BFCQ50231216-22124714-E557-4902-AC62-31F158F75170Q56287211-E93A68AF-F923-46BF-8F99-C1FF3007DCE7
P2860
Additional antibiotic inhibitors of peptidoglycan synthesis.
description
1973 nî lūn-bûn
@nan
1973年の論文
@ja
1973年論文
@yue
1973年論文
@zh-hant
1973年論文
@zh-hk
1973年論文
@zh-mo
1973年論文
@zh-tw
1973年论文
@wuu
1973年论文
@zh
1973年论文
@zh-cn
name
Additional antibiotic inhibitors of peptidoglycan synthesis.
@ast
Additional antibiotic inhibitors of peptidoglycan synthesis.
@en
type
label
Additional antibiotic inhibitors of peptidoglycan synthesis.
@ast
Additional antibiotic inhibitors of peptidoglycan synthesis.
@en
prefLabel
Additional antibiotic inhibitors of peptidoglycan synthesis.
@ast
Additional antibiotic inhibitors of peptidoglycan synthesis.
@en
P2860
P356
P1476
Additional antibiotic inhibitors of peptidoglycan synthesis.
@en
P2093
Linnett PE
P2860
P304
P356
10.1128/AAC.4.3.231
P407
P577
1973-09-01T00:00:00Z